Moreover, Liao et al. reported that the combination of cordycepin and apatinib has a synergistically anticancer effect on NSCLC cells by down-regulating VEGF/PI3K/Akt signaling pathway (Liao et al., 2020). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.